Impact of dexamethasone on the incidence of ventilator-associated pneumonia and blood stream infections in COVID-19 patients requiring invasive mechanical ventilation: a multicenter retrospective study

BACKGROUND: Dexamethasone decreases mortality in patients with severe coronavirus disease 2019 (COVID-19) and has become the standard of care during the second wave of pandemic. Dexamethasone is an immunosuppressive treatment potentially increasing the risk of secondary hospital acquired infections...

Descripción completa

Detalles Bibliográficos
Autores principales: Gragueb-Chatti, Ines, Lopez, Alexandre, Hamidi, Dany, Guervilly, Christophe, Loundou, Anderson, Daviet, Florence, Cassir, Nadim, Papazian, Laurent, Forel, Jean-Marie, Leone, Marc, Dellamonica, Jean, Hraiech, Sami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165680/
https://www.ncbi.nlm.nih.gov/pubmed/34057642
http://dx.doi.org/10.1186/s13613-021-00876-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165680/
https://www.ncbi.nlm.nih.gov/pubmed/34057642
http://dx.doi.org/10.1186/s13613-021-00876-8

Ejemplares similares